{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:40:04Z","timestamp":1787236804151,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Republika Srbija Ministarstvo prosvete nauke i tehnolo\u0161kog razvoja","doi-asserted-by":"publisher","award":["451\\u201003 \\u201068\/2022\\u2010 14\/200122"],"award-info":[{"award-number":["451\\u201003 \\u201068\/2022\\u2010 14\/200122"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bioorg.2024.107359","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T04:26:16Z","timestamp":1712636776000},"page":"107359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Discovery of a new class of potent pyrrolo[3,4-c]quinoline-1,3-diones based inhibitors of human dihydroorotate dehydrogenase: Synthesis, pharmacological and toxicological evaluation"],"prefix":"10.1016","volume":"147","author":[{"given":"Marina G.","family":"Dimitrijevi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Roschger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica G.","family":"Paunovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana D.","family":"Obradovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161 M.","family":"Mati\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijana","family":"Pocrni\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nives","family":"Gali\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrija","family":"\u0106iri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan D.","family":"Joksovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107359_b0005","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.4049\/jimmunol.170.10.4986","article-title":"Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides","volume":"170","author":"Qu\u00e9m\u00e9neur","year":"2003","journal-title":"J. Immun."},{"key":"10.1016\/j.bioorg.2024.107359_b0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40170-021-00250-z","article-title":"DHODH and cancer: promising prospects to be explored","volume":"9","author":"Zhou","year":"2021","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bioorg.2024.107359_b0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2018.10.012","article-title":"Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer","volume":"195","author":"Madak","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2024.107359_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111681","article-title":"Dihydroorotate dehydrogenase inhibitors in anti-infective drug research","volume":"183","author":"Boschi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107359_b0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/1574892812666171108124218","article-title":"Use of human dihydroorotate dehydrogenase (hDHODH) inhibitors in autoimmune diseases and new perspectives in cancer therapy","volume":"13","author":"Lolli","year":"2018","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"10.1016\/j.bioorg.2024.107359_b0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40364-020-0182-y","article-title":"Novel immunomodulatory drugs and neo-substrates","volume":"8","author":"Gao","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bioorg.2024.107359_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102129","article-title":"Vidofludimus calcium, a next generation DHODH inhibitor for the treatment of relapsing-remitting multiple sclerosis","volume":"43","author":"Muehler","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.bioorg.2024.107359_b0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1586\/17512433.2015.1019343","article-title":"Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases","volume":"8","author":"Fragoso","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107359_b0045","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1021\/acs.jmedchem.7b01862","article-title":"Design, Synthesis, and Biological Evaluation of 4-Quinoline Carboxylic Acids as Inhibitors of Dihydroorotate Dehydrogenase","volume":"61","author":"Madak","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107359_b0050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/ml300464h","article-title":"SAR-Based optimization of a 4\u2013quinoline carboxylic acid analogue with potent antiviral activity","volume":"4","author":"Das","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107359_b0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s40268-019-00286-z","article-title":"The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study","volume":"19","author":"Muehler","year":"2019","journal-title":"Drugs r&d"},{"key":"10.1016\/j.bioorg.2024.107359_b0060","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/s41375-019-0461-5","article-title":"The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies","volume":"33","author":"Christian","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.bioorg.2024.107359_b0065","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s13238-020-00801-y","article-title":"Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2","volume":"13","author":"Xiong","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.bioorg.2024.107359_b0070","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1021\/acsmedchemlett.9b00235","article-title":"The dark side of fluorine","volume":"10","author":"Pan","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107359_b0075","first-page":"435","article-title":"Inhibitory effects of 5-fluorouracil and oxaliplatin on human colorectal cancer cell survival are synergistically enhanced by sulindac sulfide","volume":"29","author":"Flis","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioorg.2024.107359_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104373","article-title":"Potent human dihydroorotate dehydrogenase inhibitory activity of new quinoline-4-carboxylic acids derived from phenolic aldehydes: synthesis, cytotoxicity, lipophilicity and molecular docking studies","volume":"105","author":"Petrovi\u0107","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107359_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128194","article-title":"Low cytotoxic quinoline-4-carboxylic acids derived from vanillin precursors as potential human dihydroorotate dehydrogenase inhibitors","volume":"46","author":"Petrovi\u0107","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107359_b0090","doi-asserted-by":"crossref","first-page":"e2200374","DOI":"10.1002\/ardp.202200374","article-title":"Synthesis and biological evaluation of new quinoline-4-carboxylic acid-chalcone hybrids as dihydroorotate dehydrogenase inhibitors","volume":"356","author":"Petrovi\u0107","year":"2023","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2024.107359_b0095","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1021\/jm048987t","article-title":"Synthesis and structure-activity relationship of 4-substituted 2-(2-acetyloxyethyl)-8-(morpholine-4-sulfonyl)pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors","volume":"48","author":"Kravchenko","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107359_b0100","unstructured":"V. Summa, P. Pace, M.E. Di Francesco, J.I.M. Hernando, E. Nizi, Heterocyclic compounds and their use as inhibitors of HCV polymerases for the treatment of HCV, UK Pat., GB 2 450 771 A (2009)."},{"key":"10.1016\/j.bioorg.2024.107359_b0105","unstructured":"K. Shaw, J. Yuan, Certain pyrroloquinolinones: A new class of GABA brain receptor, U.S. Patent No. 5,908,932 (1999)."},{"key":"10.1016\/j.bioorg.2024.107359_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2022.133236","article-title":"Rapid access to pyrrolo[3,4-c]quinoline-1,3-diones: An improved synthetic protocol using a precursor prepared by Pfitzinger reaction","volume":"132","author":"Dimitrijevi\u0107","year":"2023","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2024.107359_b0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1021\/co500002s","article-title":"Microwave-Assisted Synthesis of Diverse Pyrrolo[3,4-c]quinoline-1,3-diones and Their Antibacterial Activities","volume":"16","author":"Xia","year":"2014","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.bioorg.2024.107359_b0120","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.7150\/jca.14835","article-title":"Dihydroorotate dehydrogenase inhibitors target c-myc and arrest melanoma, myeloma and lymphoma cells at S-phase","volume":"8","author":"Dorasamy","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.bioorg.2024.107359_b0125","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.107359_b0130","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/chemosensors10080340","article-title":"Liquid chromatography on the different methods for the determination of lipophilicity: an essential analytical tool in medicinal chemistry","volume":"10","author":"Soares","year":"2022","journal-title":"Chemosensors"},{"key":"10.1016\/j.bioorg.2024.107359_b0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1367-5931(03)00055-3","article-title":"Profiling drug-like properties in discovery research","volume":"7","author":"Di","year":"2003","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2024.107359_b0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejps.2015.05.008","article-title":"Setup and validation of shake-flask procedures for the determination of partition coefficients (logD) from low drug amounts","volume":"76","author":"Andres","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2024.107359_b0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/187231208785425791","article-title":"Oxidative bioactivation and toxicity of leflunomide in immortalized human hepatocytes and kinetics of the non-enzymatic to its major metabolite, A77 1726","volume":"2","author":"Seah","year":"2008","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.bioorg.2024.107359_b0150","article-title":"Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease","volume":"33","author":"Villgran","year":"2021","journal-title":"Respir. Med. Case Rep."},{"key":"10.1016\/j.bioorg.2024.107359_b0155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0031-1296204","article-title":"Risk of hepatotoxicity with add-on leflunomide in rheumatoid arthritis patients","volume":"61","author":"Gupta","year":"2011","journal-title":"Arzneimittelforsch."},{"key":"10.1016\/j.bioorg.2024.107359_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107398","article-title":"Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review","volume":"93","author":"Alamri","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2024.107359_b0165","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10715760410001694026","article-title":"Is serum gamma glutamyltransferase a marker of oxidative stress?","volume":"38","author":"Lee","year":"2004","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bioorg.2024.107359_b0170","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/toxics10050274","article-title":"The anti-rheumatic drug, leflunomide, induces nephrotoxicity in mice via upregulation of TGF\u03b2-Mediated p53\/Smad2\/3 signaling","volume":"10","author":"Aljohani","year":"2022","journal-title":"Toxics"},{"key":"10.1016\/j.bioorg.2024.107359_b0175","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bioorg.2024.107359_b0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2019\/5080843","article-title":"Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis","volume":"2019","author":"Su","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bioorg.2024.107359_b0185","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.bbrc.2018.07.149","article-title":"Leflunomide attenuates oxidative stress in fetal human lung endothelial cells via superoxide dismutase 2 and catalase","volume":"503","author":"Shrestha","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2024.107359_b0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.22265\/acnef.3.2.229","article-title":"Nefritis t\u00fabulo intersticial por leflunomide","volume":"3","author":"Uriarte","year":"2016","journal-title":"Rev. Colomb. Nefrol."},{"key":"10.1016\/j.bioorg.2024.107359_b0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fphar.2014.00073","article-title":"Glutathione synthesis is compromised in erythrocytes from individuals with HIV","volume":"5","author":"Morris","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107359_b0200","doi-asserted-by":"crossref","first-page":"e13145","DOI":"10.1111\/jfbc.13145","article-title":"Understanding oxidants and antioxidants: Classical team with new players","volume":"44","author":"Ali","year":"2020","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.bioorg.2024.107359_b0205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00383-009-2529-1","article-title":"Effect of leflunomide on liver regeneration after partial hepatectomy in rats","volume":"26","author":"Karaman","year":"2010","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.bioorg.2024.107359_b0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cbi.2017.04.009","article-title":"Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPAR\u03b3 and Nrf2: Protective effect of 18\u03b2-Glycyrrhetinic acid, Chem.-Biol","volume":"270","author":"Mahmoud","year":"2017","journal-title":"Interact."},{"key":"10.1016\/j.bioorg.2024.107359_b0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41401-019-0283-z","article-title":"Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1\/3 and MRP2","volume":"41","author":"Liao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2024.107359_b0220","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1471-4159.1980.tb11254.x","article-title":"Peroxidative changes in brain cortical fatty acids and phospholipids, as characterized during Fe2+ - and ascorbic acid-stimulated lipid peroxidation in vitro","volume":"34","author":"Rehncrona","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bioorg.2024.107359_b0225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2024.107359_b0230","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0003-2697(90)90208-Q","article-title":"Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples","volume":"190","author":"Baker","year":"1990","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2024.107359_b0235","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase","volume":"47","author":"Marklund","year":"1974","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bioorg.2024.107359_b0240","unstructured":"E. Beutler, Red cell Metabolism: A Manual of Biochemical Methods (Ed. 2), Grune and Stratton, New York, 1975, pp. 69-73 and 89-90."},{"key":"10.1016\/j.bioorg.2024.107359_b0245","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107359_b0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9258(18)74965-X","article-title":"Spectrophotometric studies: II. Preparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin","volume":"112","author":"Drabkin","year":"1935","journal-title":"J. Biol. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824002645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824002645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:57:28Z","timestamp":1777463848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824002645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":50,"alternative-id":["S0045206824002645"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107359","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a new class of potent pyrrolo[3,4-c]quinoline-1,3-diones based inhibitors of human dihydroorotate dehydrogenase: Synthesis, pharmacological and toxicological evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107359"}}